BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21317353)

  • 1. A view on imaging in drug research and development for respiratory diseases.
    van Echteld CJ; Beckmann N
    J Pharmacol Exp Ther; 2011 May; 337(2):335-49. PubMed ID: 21317353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B
    Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary pulmonary hypertension.
    Roy R; Couriel JM
    Paediatr Respir Rev; 2006 Mar; 7(1):36-44. PubMed ID: 16473815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung MRI for experimental drug research.
    Beckmann N; Cannet C; Karmouty-Quintana H; Tigani B; Zurbruegg S; Blé FX; Crémillieux Y; Trifilieff A
    Eur J Radiol; 2007 Dec; 64(3):381-96. PubMed ID: 17931813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance imaging for assessment of lung function and respiratory dynamics.
    Eichinger M; Tetzlaff R; Puderbach M; Woodhouse N; Kauczor HU
    Eur J Radiol; 2007 Dec; 64(3):329-34. PubMed ID: 17889475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needs for animal models of human diseases of the respiratory system.
    Reid LM
    Am J Pathol; 1980 Dec; 101(3 Suppl):S89-101. PubMed ID: 6969987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiology of airway mucus clearance.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for idiopathic pulmonary fibrosis.
    Thannickal VJ; Flaherty KR; Hyzy RC; Lynch JP
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):707-27. PubMed ID: 16262559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive structural, functional, and molecular imaging in drug development.
    Rudin M
    Curr Opin Chem Biol; 2009 Jun; 13(3):360-71. PubMed ID: 19447067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local mucociliary defence mechanisms.
    Chilvers MA; O'Callaghan C
    Paediatr Respir Rev; 2000 Mar; 1(1):27-34. PubMed ID: 16263440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting remodeling in respiratory inflammation.
    Knox AJ; Pang L; Zhu YM
    Curr Opin Investig Drugs; 2000 Dec; 1(4):428-34. PubMed ID: 11249695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of relaxin in regulation of fibrosis in the lung.
    Tang ML; Samuel CS; Royce SG
    Ann N Y Acad Sci; 2009 Apr; 1160():342-7. PubMed ID: 19416216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP12A promotes mucus dysfunction during Type 2 airway inflammation.
    Lennox AT; Coburn SL; Leech JA; Heidrich EM; Kleyman TR; Wenzel SE; Pilewski JM; Corcoran TE; Myerburg MM
    Sci Rep; 2018 Feb; 8(1):2109. PubMed ID: 29391451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vascular disease associated with schistosomiasis.
    Kolosionek E; Crosby A; Harhay MO; Morrell N; Butrous G
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1467-73. PubMed ID: 21133670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
    Restrepo RD
    Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.